Medical Implant Market By Product (Orthopedic implants, Cardiovascular Implants, Spinal Implants, Neurostimulators, Opthalmic Implants, Dental Implants, Facial Implants, Breast implants) , By Biomaterial Type (Metallic Biomaterials , Ceramic Biomaterials , Polymers Biomaterials , Natural Biomaterials) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The medical implant market was valued at $112.8 billion in 2023, and is projected to reach $225.7 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
Medical implant is a medical device or tissue that is placed inside or on the surface of the body to replace mimic the functions of biological structures in individuals whose organs are damaged, dysfunctional, or impaired. They are used to restore function and provide support in patients suffering from various medical conditions or injuries. They can be made from a variety of materials, including metals, ceramics, polymers, and biological tissues. Various types of implants include orthopedic, cardiovascular, neurological, dental, ophthalmic, cochlear, and cosmetic implants.
The growth of the global medical implant market is majorly driven by alarming increase in prevalence of chronic conditions such as cardiovascular diseases, diabetes, and neurological disorders necessitates the use of implants for treatment and management, such as pacemakers, stents, and neurostimulators. Moreover, rise in geriatric population acts as a key driving force of the global market. This is attributed to the fact that increase in elderly population leads to a higher prevalence of age-related conditions such as osteoporosis, cardiovascular diseases, and degenerative joint diseases, boosting the demand for medical implants. Furthermore, rise in accidents, sports injuries, and trauma cases leads to higher demand for orthopedic implants to repair and support damaged bones and joints. Thus, these facts determine that orthopedic implants are considered the most common. According to an article published by Wolters Kluwer, a Dutch information services company, almost two million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Furthermore, increase in awareness among patients and healthcare providers about the benefits of medical implants and enhanced healthcare facilities and infrastructure in developing regions increase access to advanced medical treatments, including implant surgeries, boost the market growth. Desire for improved physical appearance has significantly propelled the demand for cosmetic surgeries and procedures, such as breast implants and facial implants, further augmenting the market growth. Growing trend of medical tourism, where patients travel to other countries for affordable and high-quality implant procedures, considerably contributes toward the market growth. According to Medical Tourism Association—a non-profit organization in Florida that focuses on raising awareness for medical travel while driving the adoption of affordable and transparent medical practices—approximately 14 million individuals travel to other countries in search of medical care annually across the world, garnering between 50 and 70 thousand million dollars. However, high cost associated with development, production, and implementation of advanced medical implants hampers the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. Furthermore, risk of immune rejection and ethical conflicts significantly restrain the market growth. On the contrary, continuous innovations in implant materials, design, and surgical techniques to improve the safety, effectiveness, and longevity of medical implants are expected to offer lucrative opportunities for the market growth during the forecast period. For instance, manufacturers are focusing on the development of implants made from biodegradable materials that gradually dissolve in the body, thus eliminating the need for surgical removal and reducing long-term complications.
The global medical implant market is segmented into product, biomaterial type, and region. On the basis of product, the market is fragmented into orthopedic implants, cardiovascular implants, spinal implants, neurostimulators, ophthalmic implants, dental implants, facial implants, and breast implants. Depending on biomaterial type, it is categorized into metallic biomaterials, ceramic biomaterials, polymers biomaterials, and natural biomaterials. Region wise, it is analyzed across North America, Europe, Asia-Pacific, LAMEA.
Key Findings
By product, the orthopedic implants segment dominated the market, in terms of share, in 2023.
Depending on biomaterial type, metallic biomaterials emerged as the leading segment in 2023.
Region wise, North America was the major shareholder in 2023.
Competition Analysis
Competitive analysis and profiles of the major players in the global medical implant market include Biotronik, Boston Scientific Corporation, CONMED Corporation, Globus Medical, Inc., Institut Straumann AG, Integra LifeSciences Holdings Corporation, LivaNova PLC, Medtronic plc, NuVasive, Inc., and Johnson & Johnson. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold and sustain the intense competition.
Key Market Segments
By Product
Orthopedic implants
Reconstructive Joint Replacements
Knee Replacement Implants
Hip Replacement Implants
Extremities
Orthobiologics
Trauma and Craniomaxillofacial
Cardiovascular Implants
Pacing Devices
Cardiac Resynchronization Therapy Devices (CRTs)
Implantable Cardioverter Defibrillators (ICDs)
Implantable Cardiac Pacemakers (ICPs)
Stents
Coronary stents
Peripheral stents
Stent-related Implants
Structural Cardiac Implants
Mechanical Heart Valves
Implantable Ventricular-assist Devices
Spinal Implants
Spinal fusion implants
Spinal bone stimulators
Vertebral Compression Fracture (VCF) Devices
Motion Preservation Devices/Non-Fusion Devices
Neurostimulators
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Spinal Cord Stimulation
Other neurostimulators
Opthalmic Implants
Intraocular Lens
Glaucoma Implants
Dental Implants
Plate Form Dental Implants
Root Form Dental Implants
Facial Implants
Breast implants
By Biomaterial Type
Metallic Biomaterials
Ceramic Biomaterials
Polymers Biomaterials
Natural Biomaterials
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Biotronik
Boston Scientific Corporation
CONMED Corporation
Globus Medical, Inc.
Institut Straumann AG
Integra LifeSciences Holdings Corporation
LivaNova PLC
Medtronic plc
NuVasive, Inc.
Johnson & Johnson
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: MEDICAL IMPLANT MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Orthopedic Implants
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.2.5. Reconstructive Joint Replacements
- 4.2.5.1. Market Size and Forecast
- 4.2.5.2. Knee Replacement Implants
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. Hip Replacement Implants
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. Extremities
- 4.2.5.2.1. Market Size and Forecast
- 4.2.6. Orthobiologics
- 4.2.6.1. Market Size and Forecast
- 4.2.7. Trauma and Craniomaxillofacial
- 4.2.7.1. Market Size and Forecast
- 4.3. Cardiovascular Implants
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.3.5. Pacing Devices
- 4.3.5.1. Market Size and Forecast
- 4.3.5.2. Cardiac Resynchronization Therapy Devices (CRTs)
- 4.3.5.2.1. Market Size and Forecast
- 4.3.5.2.2. CRT-P (CRT with pacemaker function)
- 4.3.5.2.2.1. Market Size and Forecast
- 4.3.5.2.2. CRT-D (CRT with pacemaker and ICD function)
- 4.3.5.2.2.1. Market Size and Forecast
- 4.3.5.2. Implantable Cardioverter Defibrillators (ICDs)
- 4.3.5.2.1. Market Size and Forecast
- 4.3.5.2. Implantable Cardiac Pacemakers (ICPs)
- 4.3.5.2.1. Market Size and Forecast
- 4.3.6. Stents
- 4.3.6.1. Market Size and Forecast
- 4.3.6.2. Coronary stents
- 4.3.6.2.1. Market Size and Forecast
- 4.3.6.2.2. Drug-eluting Stents (DES)
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Bare-metal Coronary Stents
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Bioabsorbable Stents
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2. Peripheral stents
- 4.3.6.2.1. Market Size and Forecast
- 4.3.6.2.2. Iliac
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Femoral-Popliteal
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Renal
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Carotid
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2. Stent-related Implants
- 4.3.6.2.1. Market Size and Forecast
- 4.3.6.2.2. Synthetic Grafts
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.6.2.2. Vena Cava Filters
- 4.3.6.2.2.1. Market Size and Forecast
- 4.3.7. Structural Cardiac Implants
- 4.3.7.1. Market Size and Forecast
- 4.3.7.2. Mechanical Heart Valves
- 4.3.7.2.1. Market Size and Forecast
- 4.3.7.2. Implantable Ventricular-assist Devices
- 4.3.7.2.1. Market Size and Forecast
- 4.3.7.2.2. LVAD
- 4.3.7.2.2.1. Market Size and Forecast
- 4.3.7.2.2. RVAD
- 4.3.7.2.2.1. Market Size and Forecast
- 4.3.7.2.2. BIVAD
- 4.3.7.2.2.1. Market Size and Forecast
- 4.4. Spinal Implants
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.4.5. Spinal fusion implants
- 4.4.5.1. Market Size and Forecast
- 4.4.6. Spinal bone stimulators
- 4.4.6.1. Market Size and Forecast
- 4.4.7. Vertebral Compression Fracture (VCF) Devices
- 4.4.7.1. Market Size and Forecast
- 4.4.8. Motion Preservation Devices/Non-Fusion Devices
- 4.4.8.1. Market Size and Forecast
- 4.5. Neurostimulators
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- 4.5.5. Deep Brain Stimulation
- 4.5.5.1. Market Size and Forecast
- 4.5.6. Sacral Nerve Stimulation
- 4.5.6.1. Market Size and Forecast
- 4.5.7. Vagus Nerve Stimulation
- 4.5.7.1. Market Size and Forecast
- 4.5.8. Spinal Cord Stimulation
- 4.5.8.1. Market Size and Forecast
- 4.5.9. Other neurostimulators
- 4.5.9.1. Market Size and Forecast
- 4.6. Opthalmic Implants
- 4.6.1. Key Market Trends, Growth Factors and Opportunities
- 4.6.2. Market Size and Forecast, By Region
- 4.6.3. Market Share Analysis, By Country
- 4.6.5. Intraocular Lens
- 4.6.5.1. Market Size and Forecast
- 4.6.6. Glaucoma Implants
- 4.6.6.1. Market Size and Forecast
- 4.7. Dental Implants
- 4.7.1. Key Market Trends, Growth Factors and Opportunities
- 4.7.2. Market Size and Forecast, By Region
- 4.7.3. Market Share Analysis, By Country
- 4.7.5. Plate Form Dental Implants
- 4.7.5.1. Market Size and Forecast
- 4.7.6. Root Form Dental Implants
- 4.7.6.1. Market Size and Forecast
- 4.8. Facial Implants
- 4.8.1. Key Market Trends, Growth Factors and Opportunities
- 4.8.2. Market Size and Forecast, By Region
- 4.8.3. Market Share Analysis, By Country
- 4.9. Breast Implants
- 4.9.1. Key Market Trends, Growth Factors and Opportunities
- 4.9.2. Market Size and Forecast, By Region
- 4.9.3. Market Share Analysis, By Country
- CHAPTER 5: MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Biomaterial Type
- 5.2. Metallic Biomaterials
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Ceramic Biomaterials
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Polymers Biomaterials
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Natural Biomaterials
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- CHAPTER 6: MEDICAL IMPLANT MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Product
- 6.2.3. Market Size and Forecast, By Biomaterial Type
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Medical Implant Market
- 6.2.5.1. Market Size and Forecast, By Product
- 6.2.5.2. Market Size and Forecast, By Biomaterial Type
- 6.2.6. Canada Medical Implant Market
- 6.2.6.1. Market Size and Forecast, By Product
- 6.2.6.2. Market Size and Forecast, By Biomaterial Type
- 6.2.7. Mexico Medical Implant Market
- 6.2.7.1. Market Size and Forecast, By Product
- 6.2.7.2. Market Size and Forecast, By Biomaterial Type
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Product
- 6.3.3. Market Size and Forecast, By Biomaterial Type
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France Medical Implant Market
- 6.3.5.1. Market Size and Forecast, By Product
- 6.3.5.2. Market Size and Forecast, By Biomaterial Type
- 6.3.6. Germany Medical Implant Market
- 6.3.6.1. Market Size and Forecast, By Product
- 6.3.6.2. Market Size and Forecast, By Biomaterial Type
- 6.3.7. Italy Medical Implant Market
- 6.3.7.1. Market Size and Forecast, By Product
- 6.3.7.2. Market Size and Forecast, By Biomaterial Type
- 6.3.8. Spain Medical Implant Market
- 6.3.8.1. Market Size and Forecast, By Product
- 6.3.8.2. Market Size and Forecast, By Biomaterial Type
- 6.3.9. UK Medical Implant Market
- 6.3.9.1. Market Size and Forecast, By Product
- 6.3.9.2. Market Size and Forecast, By Biomaterial Type
- 6.3.10. Rest Of Europe Medical Implant Market
- 6.3.10.1. Market Size and Forecast, By Product
- 6.3.10.2. Market Size and Forecast, By Biomaterial Type
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Product
- 6.4.3. Market Size and Forecast, By Biomaterial Type
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China Medical Implant Market
- 6.4.5.1. Market Size and Forecast, By Product
- 6.4.5.2. Market Size and Forecast, By Biomaterial Type
- 6.4.6. Japan Medical Implant Market
- 6.4.6.1. Market Size and Forecast, By Product
- 6.4.6.2. Market Size and Forecast, By Biomaterial Type
- 6.4.7. India Medical Implant Market
- 6.4.7.1. Market Size and Forecast, By Product
- 6.4.7.2. Market Size and Forecast, By Biomaterial Type
- 6.4.8. South Korea Medical Implant Market
- 6.4.8.1. Market Size and Forecast, By Product
- 6.4.8.2. Market Size and Forecast, By Biomaterial Type
- 6.4.9. Australia Medical Implant Market
- 6.4.9.1. Market Size and Forecast, By Product
- 6.4.9.2. Market Size and Forecast, By Biomaterial Type
- 6.4.10. Rest of Asia-Pacific Medical Implant Market
- 6.4.10.1. Market Size and Forecast, By Product
- 6.4.10.2. Market Size and Forecast, By Biomaterial Type
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Product
- 6.5.3. Market Size and Forecast, By Biomaterial Type
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Medical Implant Market
- 6.5.5.1. Market Size and Forecast, By Product
- 6.5.5.2. Market Size and Forecast, By Biomaterial Type
- 6.5.6. South Africa Medical Implant Market
- 6.5.6.1. Market Size and Forecast, By Product
- 6.5.6.2. Market Size and Forecast, By Biomaterial Type
- 6.5.7. Saudi Arabia Medical Implant Market
- 6.5.7.1. Market Size and Forecast, By Product
- 6.5.7.2. Market Size and Forecast, By Biomaterial Type
- 6.5.8. Rest of LAMEA Medical Implant Market
- 6.5.8.1. Market Size and Forecast, By Product
- 6.5.8.2. Market Size and Forecast, By Biomaterial Type
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. Biotronik
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Boston Scientific Corporation
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. CONMED Corporation
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Globus Medical, Inc.
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Institut Straumann AG
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Integra LifeSciences Holdings Corporation
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. LivaNova PLC
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Medtronic Plc
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. NuVasive, Inc.
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Johnson And Johnson
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. MEDICAL IMPLANT MARKET FOR ORTHOPEDIC IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. MEDICAL IMPLANT MARKET FOR CARDIOVASCULAR IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. MEDICAL IMPLANT MARKET FOR SPINAL IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. MEDICAL IMPLANT MARKET FOR NEUROSTIMULATORS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. MEDICAL IMPLANT MARKET FOR OPTHALMIC IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. MEDICAL IMPLANT MARKET FOR DENTAL IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. MEDICAL IMPLANT MARKET FOR FACIAL IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. MEDICAL IMPLANT MARKET FOR BREAST IMPLANTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. GLOBAL MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 11. MEDICAL IMPLANT MARKET FOR METALLIC BIOMATERIALS , BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. MEDICAL IMPLANT MARKET FOR CERAMIC BIOMATERIALS , BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. MEDICAL IMPLANT MARKET FOR POLYMERS BIOMATERIALS , BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. MEDICAL IMPLANT MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 15. MEDICAL IMPLANT MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA MEDICAL IMPLANT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 18. NORTH AMERICA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 25. EUROPE MEDICAL IMPLANT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 28. FRANCE MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 29. FRANCE MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 30. GERMANY MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 31. GERMANY MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 32. ITALY MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 33. ITALY MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 34. SPAIN MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 35. SPAIN MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 36. UK MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 37. UK MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 38. REST OF EUROPE MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 39. REST OF EUROPE MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. ASIA-PACIFIC MEDICAL IMPLANT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 41. ASIA-PACIFIC MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 42. ASIA-PACIFIC MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 43. CHINA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 44. CHINA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 45. JAPAN MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 46. JAPAN MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 47. INDIA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 48. INDIA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 49. SOUTH KOREA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 50. SOUTH KOREA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 51. AUSTRALIA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 52. AUSTRALIA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 53. REST OF ASIA-PACIFIC MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 54. REST OF ASIA-PACIFIC MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. LAMEA MEDICAL IMPLANT MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 56. LAMEA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 57. LAMEA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 58. BRAZIL MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. BRAZIL MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 60. SOUTH AFRICA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 61. SOUTH AFRICA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 62. SAUDI ARABIA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 63. SAUDI ARABIA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 64. REST OF LAMEA MEDICAL IMPLANT MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 65. REST OF LAMEA MEDICAL IMPLANT MARKET, BY BIOMATERIAL TYPE, 2024 - 2033 ($BILLION)
- TABLE 66. BIOTRONIK: KEY EXECUTIVES
- TABLE 67. BIOTRONIK: COMPANY SNAPSHOT
- TABLE 68. BIOTRONIK: OPERATING SEGMENTS
- TABLE 69. BIOTRONIK: PRODUCT PORTFOLIO
- TABLE 70. BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 71. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 72. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 73. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 74. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 75. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 76. CONMED CORPORATION: KEY EXECUTIVES
- TABLE 77. CONMED CORPORATION: COMPANY SNAPSHOT
- TABLE 78. CONMED CORPORATION: OPERATING SEGMENTS
- TABLE 79. CONMED CORPORATION: PRODUCT PORTFOLIO
- TABLE 80. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 81. GLOBUS MEDICAL, INC.: KEY EXECUTIVES
- TABLE 82. GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
- TABLE 83. GLOBUS MEDICAL, INC.: OPERATING SEGMENTS
- TABLE 84. GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
- TABLE 85. GLOBUS MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 86. INSTITUT STRAUMANN AG: KEY EXECUTIVES
- TABLE 87. INSTITUT STRAUMANN AG: COMPANY SNAPSHOT
- TABLE 88. INSTITUT STRAUMANN AG: OPERATING SEGMENTS
- TABLE 89. INSTITUT STRAUMANN AG: PRODUCT PORTFOLIO
- TABLE 90. INSTITUT STRAUMANN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
- TABLE 92. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
- TABLE 93. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
- TABLE 94. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
- TABLE 95. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. LIVANOVA PLC: KEY EXECUTIVES
- TABLE 97. LIVANOVA PLC: COMPANY SNAPSHOT
- TABLE 98. LIVANOVA PLC: OPERATING SEGMENTS
- TABLE 99. LIVANOVA PLC: PRODUCT PORTFOLIO
- TABLE 100. LIVANOVA PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 102. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 103. MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 104. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 105. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. NUVASIVE, INC.: KEY EXECUTIVES
- TABLE 107. NUVASIVE, INC.: COMPANY SNAPSHOT
- TABLE 108. NUVASIVE, INC.: OPERATING SEGMENTS
- TABLE 109. NUVASIVE, INC.: PRODUCT PORTFOLIO
- TABLE 110. NUVASIVE, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. JOHNSON AND JOHNSON: KEY EXECUTIVES
- TABLE 112. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
- TABLE 113. JOHNSON AND JOHNSON: OPERATING SEGMENTS
- TABLE 114. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
- TABLE 115. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL MEDICAL IMPLANT MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF MEDICAL IMPLANT MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN MEDICAL IMPLANT MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALMEDICAL IMPLANT MARKET
- FIGURE 10. GLOBAL MEDICAL IMPLANT MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. MEDICAL IMPLANT MARKET FOR ORTHOPEDIC IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. MEDICAL IMPLANT MARKET FOR CARDIOVASCULAR IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. MEDICAL IMPLANT MARKET FOR SPINAL IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. MEDICAL IMPLANT MARKET FOR NEUROSTIMULATORS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. MEDICAL IMPLANT MARKET FOR OPTHALMIC IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. MEDICAL IMPLANT MARKET FOR DENTAL IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. MEDICAL IMPLANT MARKET FOR FACIAL IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. MEDICAL IMPLANT MARKET FOR BREAST IMPLANTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. GLOBAL MEDICAL IMPLANT MARKET SEGMENTATION, BY BIOMATERIAL TYPE
- FIGURE 20. MEDICAL IMPLANT MARKET FOR METALLIC BIOMATERIALS , BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. MEDICAL IMPLANT MARKET FOR CERAMIC BIOMATERIALS , BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. MEDICAL IMPLANT MARKET FOR POLYMERS BIOMATERIALS , BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 23. MEDICAL IMPLANT MARKET FOR NATURAL BIOMATERIALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 24. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 26. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 27. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 28. COMPETITIVE DASHBOARD
- FIGURE 29. COMPETITIVE HEATMAP: MEDICAL IMPLANT MARKET
- FIGURE 30. TOP PLAYER POSITIONING, 2023
- FIGURE 31. BIOTRONIK: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. BIOTRONIK: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. BIOTRONIK: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. CONMED CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. GLOBUS MEDICAL, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. GLOBUS MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. GLOBUS MEDICAL, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. INSTITUT STRAUMANN AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. INSTITUT STRAUMANN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. INSTITUT STRAUMANN AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. LIVANOVA PLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. LIVANOVA PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. LIVANOVA PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. MEDTRONIC PLC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. NUVASIVE, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. NUVASIVE, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. NUVASIVE, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 58. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
- FIGURE 59. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 60. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook